We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+3.21%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$507M
AUM Growth
-$160M
(-24%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-21.48%
Top 10 Holdings %
Top 10 Hldgs %
40.1%
Holding
696
New
71
Increased
159
Reduced
213
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$11.9M |
| 2 |
Deutsche Bank
DB
|
+$11.9M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$10.4M |
| 4 |
RSX
VanEck Russia ETF
RSX
|
+$9.67M |
| 5 |
AB InBev
BUD
|
+$9.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Thailand ETF
THD
|
+$12.4M |
| 2 |
iShares MSCI South Africa ETF
EZA
|
+$12.1M |
| 3 |
iShares MSCI Peru and Global Exposure ETF
EPU
|
+$9.29M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$9.27M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.36% |
| 2 | Technology | 8.28% |
| 3 | Consumer Staples | 6.89% |
| 4 | Consumer Discretionary | 6.15% |
| 5 | Healthcare | 5.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
226
DELISTED
Marathon Oil Corporation
MRO
| $123K | 0.02% |
7,132
-882
| -11% | -$14.2K |
|
227
HP
HPQ
$26B
| $121K | 0.02% |
8,166
-1,067
| -12% | -$16.2K |
|
228
Williams Companies
WMB
$85.8B
| $119K | 0.02% |
3,826
+936
| +32% | +$28.2K |
|
229
Enbridge
ENB
$120B
| $113K | 0.02% |
2,702
| – | – |
|
230
iShares MSCI Sweden ETF
EWD
$534M
| $112K | 0.02% |
3,912
-218
| -5% | -$6.12K |
|
231
iShares MSCI Malaysia ETF
EWM
$307M
| $112K | 0.02% |
4,000
-1
| -0% | -$30 |
|
232
Vertex Pharmaceuticals
VRTX
$123B
| $112K | 0.02% |
1,521
+932
| +158% | +$75.8K |
|
233
Accenture
ACN
$106B
| $111K | 0.02% |
949
-5
| -0.5% | -$593 |
|
234
iShares MSCI South Korea ETF
EWY
$20.1B
| $108K | 0.02% |
2,025
+1,999
| +7,688% | +$109K |
|
235
BlackBerry
BB
$4.58B
| $106K | 0.02% |
15,349
+1,668
| +12% | +$12.4K |
|
236
Kimberly-Clark
KMB
$37.6B
| $105K | 0.02% |
922
+879
| +2,044% | +$102K |
|
237
APA Corp
APA
$13B
| $104K | 0.02% |
1,635
-3,492
| -68% | -$220K |
|
238
PACCAR
PCAR
$70.5B
| $104K | 0.02% |
2,435
+728
| +43% | +$29.4K |
|
239
Bristol-Myers Squibb
BMY
$129B
| $103K | 0.02% |
1,770
-14,361
| -89% | -$785K |
|
240
Duke Energy
DUK
$101B
| $103K | 0.02% |
1,321
-2,544
| -66% | -$195K |
|
|
241
CALL
AB InBev
BUD
$164B
| $101K | 0.02% |
1,526
+419
| +38% | +$47K |
|
|
CA
242
DELISTED
CA, Inc.
CA
| $101K | 0.02% |
3,168
+2,992
| +1,700% | +$95.5K |
|
243
Cognizant
CTSH
$25.2B
| $99K | 0.02% |
1,767
| – | – |
|
244
Suncor Energy
SU
$77.7B
| $98.5K | 0.02% |
3,002
+3,000
| +150,000% | +$91.9K |
|
245
VanEck Vietnam ETF
VNM
$478M
| $98.2K | 0.02% |
7,528
| – | – |
|
246
Sempra
SRE
$58.1B
| $98.1K | 0.02% |
1,950
+630
| +48% | +$32.1K |
|
247
Intel
INTC
$413B
| $95.6K | 0.02% |
2,637
+980
| +59% | +$35.1K |
|
248
Lumen
LUMN
$6.43B
| $95.5K | 0.02% |
4,015
-459
| -10% | -$11.7K |
|
249
Sabesp
SBS
$18.4B
| $85.8K | 0.02% |
50,998
+34,544
| +210% | +$60.8K |
|
250
Boston Scientific
BSX
$68.4B
| $82.2K | 0.02% |
+3,800
| New | +$82.9K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2016 Portfolio in Review
As of Q4 2016, Exane Derivatives held 696 positions worth $507M, down 24% from $666M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Exane Derivatives withdrew a net $109M in Q4 2016, closing 50 positions and reducing 213 holdings. Its most notable exit was Vale, an estimated $8.59M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 6.6% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Exane Derivatives opened a new position in Ingredion worth $4.09M.
- Exane Derivatives's largest Q4 2016 buy was Ingredion: 32,719 shares worth $4.09M.
- Exane Derivatives added most to iShares MSCI Emerging Markets ETF in Q4 2016, an estimated $11.9M increase.
- Exane Derivatives's biggest Q4 2016 reduction was iShares MSCI Thailand ETF, cutting an estimated $12.4M.
- Exane Derivatives fully exited Vale in Q4 2016, selling an estimated $8.59M.
- Exane Derivatives's ten largest holdings make up 40% of its $507M portfolio in Q4 2016.
- Exane Derivatives opened 71 new positions and closed 50 in Q4 2016.
- Exane Derivatives's portfolio value fell 24% quarter-over-quarter to $507M.
Based on Exane Derivatives's 13F filing for Q4 2016, filed 27 Jan 2017.